News Highlights

Check this page for recent news from Appili Therapeutics.

Members of the media can contact us here, or for general inquiries, contact us here.

November 15, 2022
Appili Therapeutics ATI-1701 Biodefense Vaccine Secures ~US$14 Million of Funding from the U.S. Department of Defense in Partnership with the U.S. Air Force Academy
November 10, 2022
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2023
September 22, 2022
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
August 12, 2022
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2023
August 2, 2022
Appili Therapeutics to Present at WorldLeish7 Conference in Cartagena, Columbia